(VRTX) Vertex Pharmaceuticals - Performance -5.5% in 12m
VRTX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
39.70%
#12 in Peer-Group
Rel. Strength
33.79%
#4910 in Stock-Universe
Total Return 12m
-5.53%
#64 in Peer-Group
Total Return 5y
52.94%
#24 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 25.5 |
| High / Low | USD |
|---|---|
| 52 Week High | 516.74 USD |
| 52 Week Low | 396.64 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 46.46 |
| Buy/Sell Signal +-5 | 1.07 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: VRTX (-5.5%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.28% | 31.9% | -4.56% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.02% | 56.7% | -7.85% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.86% | 34.5% | 14.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: VRTX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for VRTX
| Total Return (including Dividends) | VRTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -0.05% | 2.09% | 4.55% |
| 3 Months | -8.17% | 2.27% | 10.78% |
| 12 Months | -5.53% | -10.84% | 14.71% |
| 5 Years | 52.94% | -26.24% | 112.53% |
| Trend Score (consistency of price movement) | VRTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -24.4% | 18.8% | 79.2% |
| 3 Months | -55.7% | 71.5% | 92.9% |
| 12 Months | -26.4% | -84.3% | 44.2% |
| 5 Years | 90.6% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th55.50 | -2.10% | -4.40% |
| 3 Month | %th42.00 | -10.21% | -17.11% |
| 12 Month | %th68.50 | 5.96% | -17.64% |
| 5 Years | %th89.00 | 107.36% | -28.04% |
FAQs
Does Vertex Pharmaceuticals (VRTX) outperform the market?
Yes,
over the last 12 months VRTX made -5.53%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.84%.
Over the last 3 months VRTX made -8.17%, while XBI made 2.27%.
Performance Comparison VRTX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
VRTX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.6% | -4.6% | 4.5% | -20% |
| US NASDAQ 100 | QQQ | -3.4% | -5.6% | 2.4% | -21% |
| German DAX 40 | DAX | -2.4% | -0.1% | -8.4% | -36% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.2% | -4.2% | 6.5% | -23% |
| Hongkong Hang Seng | HSI | -2.2% | -5.8% | -11.2% | -41% |
| India NIFTY 50 | INDA | -2.2% | -2.1% | 4.8% | -5% |
| Brasil Bovespa | EWZ | -3.9% | -7.8% | -20% | -19% |
VRTX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.1% | -6.8% | -2.2% | -34% |
| Consumer Discretionary | XLY | -1% | -1.7% | 13.2% | -25% |
| Consumer Staples | XLP | 0.9% | 1.6% | 6.3% | -15% |
| Energy | XLE | 1.8% | -3.6% | 10% | -2% |
| Financial | XLF | -2.7% | -3.1% | 1.4% | -35% |
| Health Care | XLV | -1.6% | -2.1% | 11.7% | -0% |
| Industrial | XLI | -2.2% | -3.8% | -2.1% | -30% |
| Materials | XLB | -0.6% | -1.7% | 5.2% | -9% |
| Real Estate | XLRE | 1.9% | -0.1% | 7.1% | -18% |
| Technology | XLK | -3.9% | -8.9% | 1.3% | -17% |
| Utilities | XLU | -0.2% | -0.1% | 1.1% | -30% |
| Aerospace & Defense | XAR | -4.5% | -9.9% | -16.9% | -58% |
| Biotech | XBI | -0.4% | -2.1% | 18.5% | 5% |
| Homebuilder | XHB | -0.8% | -6.1% | 15.8% | -6% |
| Retail | XRT | 0.5% | -1.5% | 13.2% | -12% |
VRTX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 4.7% | -5.17% | 13.8% | 5% |
| Natural Gas | UNG | 9.6% | 9.4% | 19.7% | 2% |
| Gold | GLD | 2.4% | 2.1% | -15.4% | -47% |
| Silver | SLV | 0.8% | -3.9% | -14.1% | -28% |
| Copper | CPER | -2.9% | -4.2% | -15.2% | -21% |
VRTX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -1.3% | -3.7% | 7.7% | -8% |
| iShares High Yield Corp. Bond | HYG | -0.5% | -1.9% | 5.5% | -16% |